Lithium and preventing chemotherapy-induced peripheral neuropathy in breast cancer patients: a placebo-controlled randomized clinical trial
Abstract Background Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of some chemotherapy regimens. Lithium has been suggested for CIPN in some animal studies. We aimed to study lithium’s preventive effect on CIPN in breast cancer patients treated with taxanes and platinu...
Saved in:
Main Authors: | S. Najafi, Z. Heidarali, M. Rajabi, Z. Omidi, F. Zayeri, M. Salehi, S. Haghighat |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/69e2cadfe47f45b0b317ff23a30c1f8e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
by: Nicolas Kerckhove, et al.
Published: (2021) -
Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy
by: Sandy Eldridge, et al.
Published: (2021) -
EFFICACY AND SAFETY OF DULOXETINE IN THE TREATMENT OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: I Putu Eka Widyadharma, et al.
Published: (2021) -
An adolescent rat model of vincristine-induced peripheral neuropathy
by: Ai-Ling Li, et al.
Published: (2021) -
Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes
by: Matthew R. Trendowski, et al.
Published: (2021)